Sera Prognostics, Inc. - Class A (SERA)

♥ 436 Thanks from members

Sera Prognostics, Inc. Class A (SERA) displays mixed-to-neutral market sentiment with a live share price trading in the $1.80 to $2.17 range, an upcoming Q2 2026 earnings catalyst on August 12, 2026, and near-term price targets pointing toward modest upside around $2.41.

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →

Other Nasdaq Tickers

NASDAQ

GraniteShares 2x Long AAPL Daily ETF (AAPB)

NASDAQ

Apple Inc. (AAPL)

NASDAQ

Direxion Daily AAPL Bear 1X ETF (AAPD)

NASDAQ

Ascentage Pharma Group International - American Depository Shares (AAPG)

NASDAQ

Direxion Daily AAPL Bull 2X ETF (AAPU)

NASDAQ

Rocket Pharmaceuticals, Inc. - Warrant (RCKTW)

Entity & Market Metadata

Sector: Healthcare Industry: Life Sciences & Diagnostics Founder: Gregory C. Critchfield Founder: Quay Hua Leadership: Chenoe Hart (CEO) Leadership: Key Management Team Holder: Decheng Capital Holder: Domain Associates Holder: Gates Frontier PreemieTest Aptos Maternal Health Diagnostics Prénatal Risk Assessment Assays #SERA #Sera Prognostics #NASDAQ SERA #maternal health diagnostics #pregnancy biomarker tests